AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract HHSD200201250287CMEDIMMUNE BIOLOGICS, INC.
Overview
Award facts
- Net obligations
- $73.66M
- $73,656,495of $474.14M potential value
- Period of performance
- Sep 19, 2017 to Feb 28, 2013
- Ended
- Modifications
- 6
- Latest action Sep 21, 2017
- Contract type
- Definitive contract
- PIID HHSD200201250287C
Description of requirement
IGF::OT::IGF PEDIATRIC INFLUENZA VACCINE
Dates and value
- Award date
- Signed on Mar 28, 2012
- Potential end of performance
- Feb 27, 2013
- Current value
- $157,498,350Base and exercised options
- Potential value (if all options are exercised)
- $474,140,850
Obligations by fiscal year of action
- FY2016: -$1,650 (de-obligation)
- FY2013: $242,055
- FY2012: $73,416,090
Total across 3 fiscal years: $73,656,495
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 21, 2017. View on USAspending · Recipient on SAM.gov
Recipient
LocationGAITHERSBURG, MD
UEIGGRWFKH9YLV3
Business sizeOther than small businessSize at award, per the contracting officer
Parent companyASTRAZENECA PLC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Centers For Disease Control And Prevention
- CDC OFFICE OF ACQUISITION SERVICES
- Funded by
- Department of Health and Human Services
- Centers For Disease Control And Prevention
- CDC OFFICE OF ACQUISITION SERVICES
Place of performance
- Place of performance
- Gaithersburg, Montgomery County, Maryland 20878-2204
- Congressional district (place of performance)
- MD-06As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- Q509MEDICAL- INTERNAL MEDICINE (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 5
Contract details
- Subcontracting plan
- Plan required - incentive not includedC
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial itemA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Mar 28, 2012Base obligation at award: $1,650
- Latest action
- Sep 21, 2017 — Other administrative actionModification 6; administrative: no change in scope or value
- Latest substantive action
- Oct 29, 2015 — Supplemental agreement (within scope)Modification 4; obligation change -$1,650
- Latest funding action
- Oct 24, 2012 — Funding onlyModification 3; obligation change +$242,055; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Supplemental agreement (within scope)3
- Other administrative action2
- Funding only1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business incorporated in the U.S.C
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7523
- Contracting office code
- 75D301
- Transactions recorded under this award key
- 7
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7523
- Funding office code
- 75D301